EN
HI
Summary
As of 13 Nov, 2026, Beryl Drugs stock price is ₹24. During the trading session, the stock has moved between an intraday low of ₹24.00 and an intraday high of ₹26.00. Over the last 52 weeks, Beryl Drugs has traded between ₹15.92 and ₹29.90.
The stock has recorded a trading volume of 12,247 shares,. Its Average Traded Price (ATP) is ₹24.02, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹24.00.
Beryl Drugs has an upper circuit limit of ₹30.40 and a lower circuit limit of ₹20.28. The total value traded stands at ₹2.94 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Beryl Drugs also offers a dividend yield of 0%.
Beryl Drugs Share Price Chart
Beryl Drugs Share Key Metrics
Volume
12247.00
Market Cap
12.17 CR
LTQ@LTP
50@24.00
ATP
24.02
Var Margin
30.86 %
Circuit Range
20.28-30.4
Delivery %
0 %
Value
2.94 L
ASM/GSM
No
Market Lot
1
Beryl Drugs Resistance and Support
Pivot 25.45
Resistance
First Resistance
25.9
Second Resistance
26.45
Third Resistance
26.9
Support
First Support
24.9
Second Support
24.45
Third Support
23.9
Beryl Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 26 | 24 | -5.29% | 26 | 24 |
| Wed Nov 11 2026 | 25.48 | 25.34 | -0.55% | 26 | 25 |
| Mon Nov 09 2026 | 25.25 | 25.48 | -0.86% | 26 | 24.5 |
Beryl Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-09-02 | A.G.M. |
| 2026-08-11 | Quarterly Results |
| 2026-06-16 | Others |
| 2026-05-28 | Audited Results |
| 2026-04-01 | Notice of EGM & Others |
| 2026-02-09 | Quarterly Results |
| 2026-01-03 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-09-02 | A.G.M. |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Beryl Drugs News
Beryl Drugs Ltd - 524606 - Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter Ended 30Th September 2026
Beryl Drugs board of directors is scheduled to meet on 14 November 2026 to approve financial results for the quarter ended 30 September 2026.
Nov 06 2026 19:59:27
Beryl Drugs Management
| Name | Position |
|---|---|
| Sanjay Sethi | Managing Director |
| Sudhir Sethi | Chairman |
Beryl Drugs Similar Stocks
Emmessar Biotech & Nutrition Ltd.
28.15
2.69 (10.57%)
Venmax Drugs And Pharmaceuticals Ltd.
14.32
-0.08 (0.56%)
Sharma East India Hospitals & Medical Research Ltd
80.20
-0.03 (0.04%)
Norris Medicines Ltd.
14.26
-0.24 (1.66%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
135.00
0.00 (0.00%)
Colinz Laboratories Ltd.
70.00
3.50 (5.26%)
Beryl Drugs FAQs
The Buying Price of Beryl Drugs share is 24 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beryl Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beryl Drugs is 12.17 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beryl Drugs share price is 29.90 & 15.92. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beryl Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BERLDRG
